ArticleJapanese journal of ophthalmology2023

Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy.

Yoshiko Fukuda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.